Related Experiment Videos
The determinants of survival following reoperation on prosthetic cardiac valves
Insights
Survival after prosthetic cardiac valve reoperation is 58%. Patient functional class and reason for reoperation, not technical issues, significantly impact outcomes for these complex cardiac surgeries.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Research
Background:
- Reoperation on prosthetic cardiac valves presents unique challenges.
- Identifying survival determinants is crucial for patient management.
Purpose of the Study:
- To identify factors influencing survival in patients undergoing reoperation for prosthetic cardiac valves.
Main Methods:
- Retrospective review of 33 patients at University of Rochester Medical Center.
- Analysis of survival rates based on valve type, patient age, NYHA functional class, and indication for reoperation (paravalvular fistula, valve dysfunction, infection).
Main Results:
- Overall survival rate was 58%.
- Survival was significantly higher in New York Heart Association (NYHA) Functional Class II (77%) compared to Class III/IV (40%).
- Survival rates varied by indication: paravalvular fistula (79%), valve dysfunction (50%), and prosthetic valve infection (29%).
Conclusions:
- Determinants of survival in prosthetic valve reoperation mirror those of primary operations, emphasizing NYHA classification and indication.
- Patient factors and specific complications, rather than reoperation complexity, appear to be key survival predictors.
Abstract:
In an effort to identify the determinants of survival following reoperation on patients with prosthetic cardiac valves, the experience with a group of 33 patients at the University of Rochester Medical Center was reviewed. The survival rate was 58% (19/33). Survival was not related to the valve involved, the age of the patient, or the technical hazards of a second cardiac operation. Ten (77%) of the 13 patients in New York Heart Association (NYHA) Functional Class II survived compared with 8 (40%) of the 20 in Class III or IV. The survival rate for patients with a paravalvular fistula was 79% (11/14); with valve dysfunction, 50% (6/12); and with prosthetic valve infection, 29% (2/7). The determinants of survival seem to be similar to those for primary operation (i. e., NYHA patient classification and indication for operation) and less related to the potential operative complications of a reoperation.